Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alector Inc (NQ: ALEC )

9.460 +0.010 (+0.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 526,746
Open 9.470
Bid (Size) 8.830 (1)
Ask (Size) 10.67 (1)
Prev. Close 9.450
Today's Range 9.440 - 10.07
52wk Range 7.500 - 27.00
Shares Outstanding 82,563,921
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
 
Via Benzinga
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in... 
Via Benzinga

Performance

YTD
-54.48%
-54.48%
1 Month
-8.60%
-8.60%
3 Month
-14.16%
-14.16%
6 Month
-32.76%
-32.76%
1 Year
-58.55%
-58.55%

More News

Read More
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
Via Benzinga
Expert Ratings for Alector
Via Benzinga
Dow Climbs More Than 400 Points, S&P 500 Rises 1.5%
Via Benzinga
Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Morgan Stanley Downgrades Alector: Here's What You Need To Know
Via Benzinga
Alector: Q4 Earnings Insights
Via Benzinga
Nasdaq Jumps Over 200 Points, Crude Oil Rises Sharply
Via Benzinga
Enphase Energy, Immunocore And Some Other Big Stocks Moving Lower On Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
Via Benzinga
R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development
Via FinancialNewsMedia
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
Via Benzinga
Alector Highlights Mid-Stage Study Data On Lead Dementia Drug
Via Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Rises 100 Points; Gold Surges 2.5%
Via Benzinga
88 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Mid-Day Market Update: U.S. Stocks Turn Higher; Dow Jumps Over 400 Points
Via Benzinga
5 Stocks Insiders Are Selling
Via Benzinga
60 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Via Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.